国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2014年
8期
1516-1518
,共3页
增生性糖尿病视网膜病变%黄斑水肿%羟苯磺酸钙%依帕司他
增生性糖尿病視網膜病變%黃斑水腫%羥苯磺痠鈣%依帕司他
증생성당뇨병시망막병변%황반수종%간분광산개%의파사타
proliferative diabetic retinopathy%macular edema%Calcium Dobesilate%Epalrestat
目的：观察口服羟苯磺酸钙片联合依帕司他片,对增生性糖尿病视网膜病变( proliferative diabetic retinopathy,PDR)玻璃体切割手术后患者康复效果的影响。<br> 方法：在PDR玻璃体切割手术后患者知情同意的情况下进行随机分组,分为术后药物干预组及对照组,术后2d；3,6,9,12 mo随访视力及眼底情况,并进行比较。<br> 结果：药物干预组视力恢复及保持较好,且黄斑水肿消退情况明显优于对照组。<br> 结论：PDR患者玻璃体切割手术后,积极口服保护视网膜的药物进行干预有利于视力的提高和眼底的康复。
目的：觀察口服羥苯磺痠鈣片聯閤依帕司他片,對增生性糖尿病視網膜病變( proliferative diabetic retinopathy,PDR)玻璃體切割手術後患者康複效果的影響。<br> 方法：在PDR玻璃體切割手術後患者知情同意的情況下進行隨機分組,分為術後藥物榦預組及對照組,術後2d；3,6,9,12 mo隨訪視力及眼底情況,併進行比較。<br> 結果：藥物榦預組視力恢複及保持較好,且黃斑水腫消退情況明顯優于對照組。<br> 結論：PDR患者玻璃體切割手術後,積極口服保護視網膜的藥物進行榦預有利于視力的提高和眼底的康複。
목적：관찰구복간분광산개편연합의파사타편,대증생성당뇨병시망막병변( proliferative diabetic retinopathy,PDR)파리체절할수술후환자강복효과적영향。<br> 방법：재PDR파리체절할수술후환자지정동의적정황하진행수궤분조,분위술후약물간예조급대조조,술후2d；3,6,9,12 mo수방시력급안저정황,병진행비교。<br> 결과：약물간예조시력회복급보지교호,차황반수종소퇴정황명현우우대조조。<br> 결론：PDR환자파리체절할수술후,적겁구복보호시망막적약물진행간예유리우시력적제고화안저적강복。
AIM:To observe the rehabilitation effect of oral Calcium Dobesilate Tablets and Epalrestat Tablets on the proliferative diabetic retinopathy ( PDR ) patients after vitrectomy. <br> METHODS:After vitrectomy patients informed consent, they were randomly divided into intervention group and control group, and their vision and fundus were followed up and compared at 2d;3, 6, 9, 12mo after operation. <br> RESULTS: The recovery and sustainment of visual acuity, and subsiding of macular edema of patients in drug intervention group were significantly better than that in control group. <br> CONCLUSION: PDR patients after vitrectomy actively orally take medicine to protect retina, which can improve vision and fundus rehabilitation.
